Pantec Biosolutions AG
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Pantec Biosolutions AG
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
A preview of the emerging health care companies profiled in the current, all-profiles issue of Start-Up. This month's profile groups are "Glioblastoma Start-Ups Get Specific," "Glaucoma Start-Ups Reach Critical Mass," and "ALS on the Cusp." Plus these Start-Ups Across Health Care: EarlySense, NeoChord, and Pantec Biosolutions.
Pantec Biosolutions is developing a laser-based skin poration platform for painless intraepidermal drug delivery, particularly for large or poorly permeating molecules. Its primary focus is the $2 billion in vitro fertilization market.
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
- Drug Delivery
- Large Molecule